Article Text

Download PDFPDF

The state of gynecologic radiation therapy in low- and middle-income countries
  1. Rohini Bhatia1,
  2. Katie E Lichter2,
  3. Lavanya Gurram3,
  4. Emily MacDuffie4,
  5. Dorothy Lombe5,
  6. Gustavo R Sarria6 and
  7. Surbhi Grover7,8
  1. 1 Department of Radiation Oncology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
  2. 2 Department of Radiation Oncology, University of California San Francisco, San Francisco, California, USA
  3. 3 Department of Radiation Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India
  4. 4 Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA
  5. 5 Department of Oncology, Cancer Diseases Hospital, Lusaka, Zambia
  6. 6 Department of Radiation Oncology, University Hospital Bonn, Bonn, Nordrhein-Westfalen, Germany
  7. 7 Department of Radiation Oncology, Botswana-University of Pennsylvania Partnership, Philadelphia, Pennsylvania, USA
  8. 8 University of Pennsylvania, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA
  1. Correspondence to Dr Surbhi Grover, Department of Radiation Oncology, Botswana-University of Pennsylvania Partnership, Philadelphia, PA 19104, USA; surbhigrover{at}gmail.com

Abstract

A disproportionate burden of gynecologic malignancies occurs in low- and middle-income countries. Radiation therapy is an integral component of treatment for gynecologic malignancies both from a curative (locally advanced cervical cancer) and palliative (bleeding cervical or pelvic mass) standpoint. Critical to understanding how better to serve patients in this regard is understanding both the extent of disease epidemiology and the radiotherapy infrastructure to treat these diseases. In this review, we explore various geographic regions and how they address a unique set of challenges specific to the peoples and culture of the region. We identify common threads across regions, including sparse distribution of radiation equipment, geographic access, and specialized training. We also highlight examples of success in the use of telemedicine and cross-cultural partnerships to help bolster access to training to ensure increased access to adequate and appropriate treatment of gynecologic malignancies.

  • neoplasms
  • radiation oncology
  • radiotherapy

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Twitter @rohinikbhatia, @lombe_dorothy

  • Contributors RB and SG organized the outline for the manuscript. RB, KEL, EM, LG, DL, GS, SG all contributed to researching, writing, and editing the manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Commissioned; internally peer reviewed.